While no denoting difference was observed between the outcome of BM-MSCs (40.2 ± 2.0%) and AD-MSCs (43.8 ± 0.9%) for DAT-positive cells, DP-MSCs showed positively higher percentage of DAT-positive cells (50.8 ± 0.9%). Here, SLC6A3 is linked to Alzheimer disease.